Pituitary Iron and Volume Imaging in Healthy Controls

References

1. 1.↵
   1. Hershko C,
   2. Link G,
   3. Cabantchik I

   . Pathophysiology of iron overload. Ann N Y Acad Sci 1998; 850: 191– 201

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Borgna-Pignatti C,
   2. Rugolotto S,
   3. De Stefano P,
   4. et al

   . Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004; 89: 1187– 93

   Abstract/FREE Full Text
3. 3.↵
   1. Angelucci E,
   2. Brittenham GM,
   3. McLaren CE,
   4. et al

   . Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 2000; 343: 327– 31

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Vogiatzi MG,
   2. Macklin EA,
   3. Trachtenberg FL,
   4. et al

   . Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassanemia syndromes in north America. Br J Haematol 2009; 146: 546– 56

   CrossRefPubMedWeb of Science
5. 5.↵
   1. De Sanctis V

   . Growth and puberty and its management in thalassaemia. Horm Res 2002; 58 (suppl 1): 72– 79

   CrossRefPubMed
6. 6.↵
   1. Argyropoulou MI,
   2. Kiortsis DN,
   3. Metafratzi Z,
   4. et al

   . Pituitary gland height evaluated by MR in patients with beta-thalassemia major: a marker of pituitary gland function. Neuroradiology 2001; 43: 1056– 58

   CrossRefPubMed
7. 7.↵
   1. Argyropoulou MI,
   2. Metafratzi Z,
   3. Kiortsis DN,
   4. et al

   . T2 relaxation rate as an index of pituitary iron overload in patients with beta-thalassemia major. AJR Am J Roentgenol 2000; 175: 1567– 69

   PubMed
8. 8.↵
   1. Wood JC,
   2. Enriquez C,
   3. Ghugre N,
   4. et al

   . MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005; 106: 1460– 65

   Abstract/FREE Full Text
9. 9.↵
   1. Noetzli LJ,
   2. Papudesi J,
   3. Coates TD,
   4. et al

   . Pancreatic iron loading predicts cardiac iron loading in thalassemia major. Blood 2009; 114: 4021– 26

   Abstract/FREE Full Text
10. 10.↵
    1. Christoforidis A,
    2. Haritandi A,
    3. Perifanis V,
    4. et al

    . MRI for the determination of pituitary iron overload in children and young adults with beta-thalassanemia major. Eur J Radiol 2007; 62: 138– 42. Epub 2006 Dec 11

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Berkovitch M,
    2. Bistritzer T,
    3. Milone SD,
    4. et al

    . Iron deposition in the anterior pituitary in homozygous beta-thalassemia: MRI evaluation and correlation with gonadal function. J Pediatr Endocrinol Metab 2000; 13: 179– 84

    CrossRefPubMed
12. 12.↵
    1. Hekmatnia A,
    2. Radmard AR,
    3. Rahmani AA,
    4. et al

    . Magnetic resonance imaging signal reduction may precede volume loss in the pituitary gland of transfusion-dependent beta-thalassemic patients. Acta Radiol 2010; 51: 71– 77

    Abstract/FREE Full Text
13. 13.↵
    1. Wood JC,
    2. Noetzl L,
    3. Hyderi A,
    4. et al

    . Predicting pituitary iron and endocrine dysfunction. Ann N Y Acad Sci 2010; 1202: 123– 28

    CrossRefPubMed
14. 14.↵
    1. Marziali S,
    2. Gaudiello F,
    3. Bozzao A,
    4. et al

    . Evaluation of anterior pituitary gland volume in childhood using three-dimensional MRI. Pediatr Radiol 2004; 34: 547– 51

    PubMed
15. 15.↵
    1. Fink AM,
    2. Vidmar S,
    3. Kumbla S,
    4. et al

    . Age-related pituitary volumes in prepubertal children with normal endocrine function: volumetric magnetic resonance data. J Clin Endocrinol Metab 2005; 90: 3274– 78

    CrossRefPubMed
16. 16.↵
    1. Takano K,
    2. Utsunomiya H,
    3. Ono H,
    4. et al

    . Normal development of the pituitary gland: assessment with three-dimensional MR volumetry. AJNR Am J Neuroradiol 1999; 20: 312– 15

    Abstract/FREE Full Text
17. 17.↵
    1. Safarinejad MR

    . Evaluation of semen quality, endocrine profile and hypothalamus-pituitary-testis axis in male patients with homozygous beta-thalassemia major. J Urol 2008; 179: 2327– 32

    CrossRefPubMed
18. 18.↵
    1. Safarinejad MR

    . Reproductive hormones and hypothalamic-pituitary-ovarian axis in female patients with homozygous beta-thalassemia major. J Pediatr Hematol Oncol 2010; 32: 259– 66

    CrossRefPubMed
19. 19.↵
    1. Karabulut A,
    2. Balci Y,
    3. Demirlenk S,
    4. et al

    . Gonadal dysfunction and pelvic sonographic findings in females with thalassaemia major. Gynecol Endocrinol 2010; 26: 307– 10

    CrossRefPubMed
20. 20.↵
    1. Ghugre NR,
    2. Enriquez CM,
    3. Coates TD,
    4. et al

    . Improved R2* measurements in myocardial iron overload. J Magn Reson Imaging 2006; 23: 9– 16

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Farmaki K,
    2. Tzoumari I,
    3. Pappa C,
    4. et al

    . Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major. Br J Haematol 2010; 148: 466– 75

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Argyropoulou MI,
    2. Kiortsis DN,
    3. Astrakas L,
    4. et al

    . Liver, bone marrow, pancreas and pituitary gland iron overload in young and adult thalassemic patients: a T2 relaxometry study. Eur Radiol 2007; 17: 3025– 30

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Rodrigue KM,
    2. Haacke EM,
    3. Raz N

    . Differential effects of age and history of hypertension on regional brain volumes and iron. Neuroimage 2011; 54: 750– 59. Epub 2010 Oct 20

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Lam WW,
    2. Au WY,
    3. Chu WC,
    4. et al

    . One-stop measurement of iron deposition in the anterior pituitary, liver, and heart in thalassemia patients. J Magn Reson Imaging 2008; 28: 29– 33

    CrossRefPubMed
25. 25.↵
    1. Liu RS,
    2. Lemieux L,
    3. Bell GS,
    4. et al

    . A longitudinal study of brain morphometrics using quantitative magnetic resonance imaging and difference image analysis. Neuroimage 2003; 20: 22– 33

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Scahill RI,
    2. Frost C,
    3. Jenkins R,
    4. et al

    . A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol 2003; 60: 989– 94

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Saisho Y,
    2. Butler AE,
    3. Meier JJ,
    4. et al

    . Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat 2007; 20: 933– 42

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Malmed S

    . The Pituitary. Malden, Massachusetts: Blackwell Science; 2002
29. 29.↵
    1. Behl C,
    2. Skutella T,
    3. Lezoualc'h F,
    4. et al

    . Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 1997: 51: 535– 41

    Abstract/FREE Full Text
30. 30.↵
    1. Naing S,
    2. Frohman LA

    . The empty sella. Pediatr Endocrinol Rev 2007; 4: 335– 42

    PubMed